← Back to Search

Behavioural Intervention

Over ground walking exercise for Multiple Sclerosis (PRIMERS Trial)

Q: Is it possible for me to participate in this ongoing medical study?

Patients eligible for this clinical trial should have a diagnosis of <a href="https://www.withpower.com/clinical-trials/multiple-sclerosis">multiple sclerosis</a> and fall within the age range of 18 to 65. The study is currently seeking approximately 24 qualified individuals to participate.

Q: Are there any available vacancies for potential participants in this research study?

According to the information available on clinicaltrials.gov, this specific trial is no longer accepting participants. It was initially posted on February 19th, 2024 and last updated on January 22nd, 2024. Despite this particular study being closed for recruitment, there are currently an additional 530 ongoing trials actively seeking eligible patients.

Q: Are individuals aged 45 and above eligible to participate in this medical trial?

This clinical trial is seeking individuals who have surpassed the age of 18 and are under the age of 65 for participant recruitment.

Phase < 1

Recruiting

Research Sponsored by Kessler Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Relapse-free for at least 30 days

Clinically-definite MS diagnosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up weeks 2 and 3

Awards & highlights

PRIMERS Trial Summary

This trial will involve participants who will be screened to make sure they can safely participate in an exercise study. If they meet the criteria, they will visit the Kessler Foundation three times. During the first

Who is the study for?

This trial is for individuals with Multiple Sclerosis who can safely participate in exercise studies. They'll need to visit the Kessler Foundation three times, be able to walk at a set pace with a FitBit, and pass cognitive tests and fitness assessments.Check my eligibility

What is being tested?

The study examines how moderate intensity walking affects brain function in people with Multiple Sclerosis. Participants will have MRI scans before and after treadmill or overground walking exercises to measure changes in brain activity and blood flow.See study design

What are the potential side effects?

Since this trial involves moderate walking exercise, potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue. The risk of falls could also be considered for those with mobility issues.

PRIMERS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been free from cancer relapse for at least 30 days.

Select...

I have been officially diagnosed with multiple sclerosis.

PRIMERS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ weeks 2 and 3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~weeks 2 and 3

This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 2 and 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Brain Blood Flow

Brain Function

Other outcome measures

Aerobic fitness

Average steps per day

Cognitive processing speed

+3 more

PRIMERS Trial Design

2Treatment groups

Experimental Treatment

Group I: Treadmill walking exerciseExperimental Treatment1 Intervention

Participants will walk on a motor-driven treadmill at a step rate of ~100 steps per minute for 20 minutes while wearing a Fitbit around the waist for measuring steps.

Group II: Over ground walking exerciseExperimental Treatment1 Intervention

Participants will walk around a square hallway at a step rate of ~100 steps per minute for 20 minutes while wearing a Fitbit around the waist for measuring steps.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor

174 Previous Clinical Trials

10,714 Total Patients Enrolled

32 Trials studying Multiple Sclerosis

1,593 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this ongoing medical study?

"Patients eligible for this clinical trial should have a diagnosis of multiple sclerosis and fall within the age range of 18 to 65. The study is currently seeking approximately 24 qualified individuals to participate."

Answered by AI

Are there any available vacancies for potential participants in this research study?

"According to the information available on clinicaltrials.gov, this specific trial is no longer accepting participants. It was initially posted on February 19th, 2024 and last updated on January 22nd, 2024. Despite this particular study being closed for recruitment, there are currently an additional 530 ongoing trials actively seeking eligible patients."

Answered by AI